Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Nobuko Kobayashi
Advertisement
Nobuko Kobayashi is a partner in global management consulting firm A.T. Kearney’s Consumer Goods and Retail Practice, serving Japanese and multinational clients in consumer industries.
Articles by Nobuko Kobayashi
Big Data & Japan's Aging Population: Opening the Door for US Pharma
Published: | Updated:
Innovations in Big Data will have a lasting impact on care and present an opportunity for U.S. pharmaceutical companies, writes Nobuko Kobayashi.
Advertisement
Latest Updated Articles
- Big Data & Japan's Aging Population: Opening the Door for US Pharma
Published: May 14th 2018 | Updated: November 15th 2020
Japan: Balancing Cost and Innovation through PricingPublished: July 9th 2018 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5